Molecular Design

Refine lead structures for preclinical success.

Enhance binding affinity, kinetic stability, and drug-like properties using GROMACS molecular dynamics, ML-driven QSAR models, and ADMET toxicity filters.

Refine lead structures for preclinical success.
Lead Optimization

Refine hit compounds into selective, drug-like leads.

Improve target selectivity, binding affinity, and metabolic stability while minimizing off-target toxicity.

Molecular dynamics (MD) simulations
Verify binding stability and structural flexibility over time using GROMACS and AMBER.
Free energy calculations
Refine docking predictions with MM-GBSA and Free Energy Perturbation (FEP) scoring.
ADMET predictive modeling
Assess bioavailability, hepatic clearance, BBB permeation, and hERG toxicity using pkCSM and SwissADME.
GROMACSHigh-performance molecular dynamics simulator. AMBERAssisted Model Building with Energy Refinement suite. SwissADMEPredicts ADME parameters, drug-likeness, and medicinal chemistry friendliness. pkCSMPredicts small-molecule pharmacokinetics using graph signatures. MM-GBSAMolecular Mechanics Generalized Born Surface Area calculations.
Why RASA

Why Choose RASA?

AI-Assisted Bioinformatics

Machine learning-enabled workflows for biomarker discovery, variant prioritization, and predictive genomics.

Multi-Platform Expertise

Support for Illumina, Oxford Nanopore, PacBio HiFi, and 10x Genomics platforms.

End-to-End Analysis

From raw sequencing data to biological interpretation and publication-ready reports.

Cloud-Ready Infrastructure

Deployable on AWS, Google Cloud, HPC clusters, and secure on-premise environments.

Reproducible Workflows

Built using Nextflow, Snakemake, Docker, and Singularity for enterprise-grade bioinformatics operations.

Accelerate therapeutic discovery with RASA.

Get in touch with our Pune-based computational drug design experts to coordinate target screens or dynamics calculations.

Start a Project